Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain
Howard S Smith,1 Timothy R Deer21Albany Medical College, Department of Anesthesiology, Albany, New York, USA; 2The Center for Pain Relief, Clinical Professor, West Virginia, University, Charleston, West Virginia, USAAbstract: Ziconotide is a conopeptide intrathecal (IT) analgesic which is approved b...
Saved in:
Main Authors: | Howard S Smith (Author), Timothy R Deer (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2009-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serious pain treatment with intrathecal ziconotide pathway - clinical case
by: Giovanni Nicotera, et al.
Published: (2008) -
Simultaneous Determination of Sufentanil and Ziconotide in Combination for Intrathecal Analgesia by UPLC-UV
by: Sorrieul Jérémy, et al.
Published: (2016) -
Ziconotide in severe, drug-resistant cancer pain. preliminary experience
by: Angelo Lavano
Published: (2008) -
Efficacy and Safety of Ropivacaine Addition to Intrathecal Morphine for Pain Management in Intractable Cancer
by: Ying Huang, et al.
Published: (2015) -
Intracisternal ziconotide infusion. Clinical case of an inoperable pharynx cancer patient with severe cervico-facial pain syndrome
by: Sergio Mameli, et al.
Published: (2015)